We demonstrated that, in contrast to classical opioid receptors, ACKR3 doesn't set off classical G protein signaling and is not modulated by the classical prescription or analgesic opioids, such as morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we established that LIH383, an ACKR3-selective https://stratfordc134ekk0.blogsuperapp.com/profile